Pharmacogenomics Clinical Decision Support Systems

Abstract

Get full access to this article

View all access options for this article.

References

Dylan

. The Times They Are a-Changin’. New York: Columbia Records, 1964. Available from: https://www.youtube.com/watch?v=90WD_ats6eE [Last accessed: July 31, 2024].

Hedgecoe

. Terminology and the construction of scientific disciplines: The case of pharmacogenomics. Science Technol Hum Values, 2003; 28(4):513–537; doi: 10.1177/0162243903256274

Kalow

. Pharmacogenetics. Heredity and the Response to Drugs. Philadelphia, PA: W.B. Saunders Co., 1962.

Kalow

, Ozdemir

, Tothfalusi

. Multigenic traits and risk assessment in pharmacology: A population approach. Pharmacogenomics J, 2001; 1(4):234–236; doi: 10.1038/sj.tpj.6500061

Lin

, Wu

. Digital transformation in personalized medicine with artificial intelligence and the internet of medical things. OMICS, 2022; 26(2):77–81; doi: 10.1089/omi.2021.0037

Marshall

. Genset-Abbott deal heralds pharmacogenomics era. Nat Biotechnol, 1997; 15(9):829–830; doi: 10.1038/nbt0997-829b

Motulsky

. Drug reactions, enzymes, and, biochemical genetics. J Am Med Assoc, 1957; 165(7):835–837; doi: 10.1001/jama.1957.72980250010016

Ozdemir

, Kalow

, Tothfalusi

, et al. Multigenic control of drug response and regulatory decision-making in pharmacogenomics: The need for an upper-bound estimate of genetic contributions. Curr Pharmacogenomics, 2005; 3(1):53–71; doi: 10.2174/1570160053175027